-
Mashup Score: 0
Speakers: Drs. C. Michael Gibson and Julia GrapsaACC Medical Correspondent Dr. C. Michael Gibson and JACC: Case Reports Editor-in-Chief Dr. Julia Grapsa talk…
Source: YouTubeCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
For a broad range of patients with heart failure, reduced left ventricular ejection fraction and iron deficiency, intravenous ferric derisomaltose administration was associated with a lower risk of hospital admissions for heart failure and cardiovascular death, further supporting the benefit of iron repletion in this population.
Source: The LancetCategories: Cardiologists, Latest HeadlinesTweet-
#IRONMAN For a broad range of patients with #HeartFailure ( #LVEF ≤45%) and Fe deficiency, IV ferric derisomaltose 💉 was associated with a ⬇️ risk of 🏥 admissions for HF and CV ☠️ https://t.co/y95VCN9I94 #AHA22 @TheLancet @ShelleyZieroth @hswapnil @gcfmd @WilfriedMullens https://t.co/oKHqrSjMpM https://t.co/W0dZqoiygi
-
-
Mashup Score: 8
For a broad range of patients with heart failure, reduced left ventricular ejection fraction and iron deficiency, intravenous ferric derisomaltose administration was associated with a lower risk of hospital admissions for heart failure and cardiovascular death, further supporting the benefit of iron repletion in this population.
Source: The LancetCategories: Cardiologists, Latest HeadlinesTweet-
#IRONMAN @TheBHF #AHA22 Impact of IV iron on HF hosp🏥/CV 💀 Randomized HFrEF pts to IV Ferric Derisomaltose or placebo Primary endpoint 18% ⬇️ CV 💀 & recurrent HF 🏥but CV 💀p=.23 Covid sensitivity analysis ⬆️p Safe:no excess adverse events https://t.co/Oy2FyJYbkL @TheLancet https://t.co/teRrb28Jcu
-
-
Mashup Score: 0CRISPR, COACH, PRO-HF, IRONMAN Trials Explore Breakthrough HF Strategies - American College of Cardiology - 2 year(s) ago
Late-breaking science exploring breakthrough strategies in the heart failure (HF) journey were the focus of a special session Nov. 5 during AHA 2022 in Chicago. Researchers presented findings from the CRISPR, COACH, PRO-HF and IRONMAN trials. In CRISPR, a single intravenous infusion of NTLA-2001, a novel gene-editing therapy based on CRISPR/Cas9, significantly reduced abnormal levels of the…
Source: American College of CardiologyCategories: Cardiology News and Journals, Latest HeadlinesTweet-
Late-breaking science at #AHA22 sheds light on breakthrough strategies in managing and treating #HeartFailure. Get the highlights from #CRISPR, COACH, PRO-HF and #IRONMAN trials here: https://t.co/Me1vSnYlX2 #CardioTwitter #CardioEd https://t.co/rWffJ7Xv7S
-
-
Mashup Score: 17
For a broad range of patients with heart failure, reduced left ventricular ejection fraction and iron deficiency, intravenous ferric derisomaltose administration was associated with a lower risk of hospital admissions for heart failure and cardiovascular death, further supporting the benefit of iron repletion in this population.
Source: The LancetCategories: Cardiologists, Latest HeadlinesTweet-
Another win for IV iron in HF! Now with a different iron formulation. #IRONMAN now out in @TheLancet with #AHA22 https://t.co/eLLEQoZ0Rm
-
-
Mashup Score: 0
APCCC 2022 updates from the IRONMAN Project, APCCC Movember session, localized prostate cancer treatment, advanced prostate cancer treatment, metastatic hormone sensitive prostate cancer, global IRONMAN registry.
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet-
#APCCC22 #Movember Session: Update on @Movember and the #IRONMAN Project. Presentation by Jane Fisher, PhD and @Daniel_J_George. Written coverage by @zklaassen_md @GACancerCenter on UroToday > https://t.co/nPLgKPz15c @IRONMANregistry @DukeGUCancer @APCCC_Lugano https://t.co/qo4chwaW31
-
-
Mashup Score: 2ASCO GU 2022: First Look at Patient Reported Outcomes from IRONMAN, the International Registry of Men with Advanced Prostate Cancer - 2 year(s) ago
ASCO GU 2022 first results from IRONMAN, patient reported outcomes in an international registry of men with advanced prostate cancer, advanced prostate cancer survivors.
Source: www.urotoday.comCategories: Latest Headlines, UrologyTweet-
First look at patient-reported outcomes from #IRONMAN, the International Registry of men with advanced #ProstateCancer. Presentation by @EmilyRencsok @HarvardChanSPH. #GU22 written coverage by @zklaassen_md @GACancerCenter > https://t.co/g1IgigTFO0 @IRONMANregistry @ASCO https://t.co/d0BuhnyJYN
-
-
Mashup Score: 2
When designing futuristic humanoid robots, what has sci-fi taught us the number one thing it absolutely needs is? That’s right – a jetpack. Luckily, a team
Source: IFLScienceCategories: Healthcare Professionals, Latest HeadlinesTweet-
RT @GlenGilmore: Researchers Are Building A Humanoid Robot That Flies Like Iron Man 🚀 https://t.co/PHbq903HYs @IFLScience #ironman #Robotic…
-
-
Mashup Score: 24
A mountain ambulance service in England is testing a jet suit that would allow paramedics to fly to patients in remote locations in just minutes.
Source: USA TODAYCategories: Future of Medicine, Latest HeadlinesTweet-
RT @SpirosMargaris: A #IronMan jet suit could help #paramedics save #lives in minutes in #UK https://t.co/ilQ4kAI5sY #fintech #healthcar…
-
-
Mashup Score: 0The IRONMAN - An International Registry for Men with Advanced Prostate Cancer - Dana Rathkopf - 4 year(s) ago
At the 26th Annual Prostate Cancer Foundation Scientific Retreat (PCF 2019) Dana Rathkopf and Alicia Morgans discuss the IRONMAN registry. Dana, a strong contributor to the IRONMAN registry trial, explains the goals of the registry and why it is so important for the personalization of patient care around the world. The IRONMAN registry is a population-based observational study currently in nine…
Source: UroTodayCategories: UrologyTweet-
#IRONMAN - An international registry for men with adv. #ProstateCancer. @DRathkopf @sloan_kettering and @CaPsurvivorship @NUFeinbergMed on the goals and why it is so important for the personalization of patient care around the world. #WatchNow > https://t.co/5Wempp6UNv @PCFnews https://t.co/wz3Bn1FTrZ
-
ACC Medical Correspondent @CMichaelGibson and #JACCCaseReports EiC @JGrapsa talk key insights and takeaways from #TRANSFORM, #CRISPR and #IRONMAN trials presented during #AHA22 as part of the latest #ACCessPoints video. #CardioTwitter @JACCJournals https://t.co/FZ2gtalnkx